Levodopa/Carbidopa/Entacapone Teva

Levodopa/Carbidopa/Entacapone, the active ingredient in Levodopa/Carbidopa/Entacapone Teva, is an antiparkinson agent presented as a tablet for oral use. It treats Parkinson's disease by improving motor function in adult patients. GNH USA supplies Levodopa/Carbidopa/Entacapone Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levodopa/Carbidopa/Entacapone is an antiparkinson combination that targets dopaminergic pathways in Parkinson's disease. - Parkinson's disease: improves motor symptoms and reduces "off" periods. - Levodopa‑responsive Parkinsonism: provides more stable central dopamine levels. - Fluctuating Parkinsonian symptoms: helps smooth daily symptom control.

Levodopa/Carbidopa/Entacapone may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Dizziness: especially when standing quickly. - Orthostatic hypotension: drop in blood pressure upon standing. - Headache: transient cranial discomfort. - Insomnia: difficulty falling or staying asleep. - Dry mouth: reduced salivation.

Serious or Rare Side Effects: - Dyskinesia: involuntary, erratic movements. - Hallucinations: visual or auditory disturbances. - Severe hypotension: marked drop in blood pressure requiring medical attention. - Cardiac arrhythmias: irregular heart rhythms. - Neuroleptic malignant syndrome: rare but life‑threatening reaction. - Anaphylaxis: severe allergic response.

When prescribing Levodopa/Carbidopa/Entacapone, clinicians should consider several safety factors. - Renal or hepatic impairment: monitor liver and kidney function regularly. - Cardiovascular disease: observe blood pressure and heart rate for instability. - Psychiatric history: watch for emergence of hallucinations or confusion. - Pregnancy: use only if potential benefit outweighs unknown risk to the fetus. - Elderly patients: increased risk of falls and orthostatic hypotension. - Store below 25°C: keep in the original packaging, protect from moisture and light.

Levodopa/Carbidopa/Entacapone can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Non‑selective MAO‑B inhibitors: may precipitate hypertensive crisis. - Antipsychotics (dopamine antagonists): can block therapeutic benefit. - Anticholinergic agents: may diminish motor improvement.

Moderate Interactions (Monitor Closely): - SSRIs or SNRIs: increased risk of serotonin syndrome. - Diuretics: may exacerbate orthostatic hypotension. - Iron or calcium supplements: can reduce levodopa absorption if taken simultaneously.